•  

     

    World Biosimilar Congress USA

     

    Cost-effective biologics for payers, prescribers and patients

    A multi-streamed, co-located conference & technology exhibition

    March 4th– 5th 2019

 

50+ Exhibitors  |  200+ Speakers  |  600+ 1-2-1 Meetings

 

Congress Speakers

Hubert Chen, Chief Medical & Scientific Officer, Pfenex Hubert Chen
Chief Medical & Scientific Officer
Pfenex

Bruce Leicher, Senior Vice President and General Counsel, Momenta Pharmaceuticals, Inc. Bruce Leicher
Senior Vice President and General Counsel
Momenta Pharmaceuticals, Inc.

Julio Baez, Former Head Technology, Cipla Biotech Julio Baez
Former Head Technology
Cipla Biotech

Peg Ford, President, Ovarian Cancer Alliance of San Diego Peg Ford
President
Ovarian Cancer Alliance of San Diego

Jeff Myers, CEO, Medicaid Plans of America Jeff Myers
CEO
Medicaid Plans of America

Bryan Kim, Vice President, Business Development, Samsung Bioepis Bryan Kim
Vice President, Business Development
Samsung Bioepis

 
 

Congress Topics

 
 
 

WHAT IS THE WORLD BIOSIMILAR CONGRESS USA?

Networking


It’s not just about the conference sessions, our Congress recognises the importance of networking.

With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.

Conference


The World Biosimilar Congress USA brings together the pioneers doing the most innovative work within the industry and across the whole value chain, to share their unique insights with you.

The event looks at commercialising and pushing forward the entire developmental pipeline as well as focusing on the hottest new individual therapeutics.

Exhibition

Exhibit at Work 2.0


This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.

Sponsorship packages are tailored to meet your specific marketing goals. And, the exhibition floor does sell out, so don’t delay.

 

2019 Advisory Board

The agenda is being shaped by an industry advisory board, with members including

 

Roy Baynes, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)

Roy Baynes
SVP and Head Global Clinical Development, Chief Medical Officer
Merck, Sharp & Dohme (MSD)

Hans Klingemann, Vice President of Research and Development, NantKwest

Hans Klingemann
Vice President of Research and Development
NantKwest

Mark Chiu, Associate Director, Multispecific Biologics Engineering, Janssen Research & Development

Mark Chiu
Associate Director, Multispecific Biologics Engineering
Janssen Research & Development

Michael DeRidder, Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy, GSK

Michael DeRidder
Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy
GSK

Partha Chowdhury, Senior Director and Head, Antibody Discovery, Sanofi Genzyme

Partha Chowdhury
Senior Director and Head, Antibody Discovery
Sanofi Genzyme

Kevin Johnson, Partner, Medicxi

Kevin Johnson
Partner
Medicxi

Alexey Rak, Head of Bio Structure and Biophysics, Sanofi

Alexey Rak
Head of Bio Structure and Biophysics
Sanofi

 
 
 

Who Attends

 

AbbVie Abzena ADC Therapeutics Alligator Bioscience Amgen AstraZeneca Biogen Biosim Spanish Association of Biosimilars Boehringer Ingelheim Bristol Myers Squibb Cancer Research UK Cinfa Biotech GmbH Dr. Reddy's Laboratories SA. Duke University Medical Centre Eli Lilly & Co European Molecular Biology Laboratory European Patent Office European Specialist Nurses Organisations Ferrer International Fraunhofer IME Gedeon Richter Goldstein & Fox GSK HPAPI Project Services Ltd Janssen Libbs Pharmaceutica Lonza mAbs Macrogenics Maverick Therapeutics MedImmune Merck Merck, Sharp & Dohme (MSD) Napp pharmaceuticals NAPP Pharmaceuticals NBE Therapeutics NHS NIBR NICE NIHR Clinical Research Network (NIHR CRN) Norwegian Medicines Agency Novartis NovImmune NxR Biotechnologies Opsona Therapeutics Oril Industrie Ossianix PAREXEL Paul Ehrlich Institute Pfizer Biotherapeutics Pieris Pharmaceuticals Pierre Fabre Prima BioMed Roche Roche S.A.Toral SafeBridge Sandoz Biopharmaceuticals Sandoz Sanofi Sanofi R&D Sanquin Seattle Genetics Technische Universität Braunschweig Teva Pharmaceuticals The Royal Marsden NHS Foundation Trust Therapeomic TU Wien UCB Celltech University of Cambridge University of Denmark University of Messina – Italy University of Stuttgart

 

FIND OUT MORE

 
 


Put your company at the forefront of the mAbs community and sponsor the World Biosimilar Congress USA.

Download the prospectus to see how you can get involved.

 
 
 
 

 

GET INVOLVED AT THE  FESTIVAL OF BIOLOGICS USA

 

To Sponsor Or Exhibit

 

Derek Cavanagh
derek.cavanagh@terrapinn.com
t/ +44 (0)207 092 1297

 

 

 

To Speak

 

Joan Shutt
joan.shutt@terrapinn.com
t/ +44 (0)207 092 1134

 

 

 

To Register

 

Tayyab Abbasi
Tayyab.Abbasi@terrapinn.com
t/ +44 (0)207 092 1210